Latest Research in Dermatomyositis and Scleroderma Remodeling

Top Research Topics in Dermatomyositis and Scleroderma Remodeling

• Inflammatory Myopathies and Dermatomyositis — 26 papers
• Systemic Lupus Erythematosus Research — 12 papers
• Systemic Sclerosis and Related Diseases — 12 papers
• Salivary Gland Disorders and Functions — 3 papers
• Autoimmune and Inflammatory Disorders Research — 3 papers
• Hepatitis B Virus Studies — 2 papers
• Autoimmune Neurological Disorders and Treatments — 2 papers
• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis — 2 papers
• Vitamin D Research Studies — 2 papers
• Polyomavirus and related diseases — 2 papers

Highest-Cited Papers

1. Gender-Related Differences in the Clinical, Immunological, and Treatment Characteristics of Patients with Systemic Lupus Erythematosus
2. Immune–vascular–fibrotic remodeling defines a neuroimmune tissue niche in systemic sclerosis skin and converges with human peripheral nerve injury programs
3. Neurologic impairment evaluation of patients with primary Sjögren’s syndrome: a cross-sectional study
4. Lessons from arthritis and osteomyelitis mimicking juvenile idiopathic arthritis: painlessness as an important clue to NTRK1 mutations
5. Multicenter Clinical Comparison Between Anti‐ NXP2 and Anti‐ TIF1 ‐γ Antibody‐Positive Myositis, and Analysis of the Clinical Significance of Anti‐ NXP2 Antibody Titers in Idiopathic Inflammatory Myopathies
6. Myeloma‐Associated Sporadic Late‐Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report
7. Associations Between Mental Health Diagnoses and Recurrent Acute Care Use Among Individuals with Systemic Lupus Erythematosus in the All of Us
8. Dr. Schock et al reply
9. Remission, low disease activity, and relapse in patients with juvenile-, adult-, and late-onset systemic lupus erythematosus
10. Prevalence and Clinical Associations of Systemic Sclerosis-Related Autoantibodies: A Nationwide Reuma.pt Cohort Study
11. Incidence and disease course of polymyalgia rheumatica during two decades: a nationwide study across healthcare sectors in Denmark
12. Intravenous Cyclophosphamide Infusion and miRNA-29A, miRNA-16, IL-6, TGF-β1 Responses in Systemic Sclerosis Patients with Interstitial Lung Disease
13. Clinical features and a Nomogram for predicting clinical response in juvenile dermatomyositis associated interstitial lung disease
14. Transition From Systemic Sclerosis to Interstitial Lung Disease: Methodological Considerations
15. Pain Phenotypes in Patients with Inflammatory Myopathies: A Latent Class Analysis
16. Oral aphthosis in children: baseline clinical features associated with diagnostic categories in a single-centre retrospective cohort
17. Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies
18. Lysophosphatidylcholine-induced macrophage polarization imbalance and functional dysregulation in immune thrombocytopenia
19. Expert Perspective: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies
20. Ultrasensitive serum levels of interleukin 13 in systemic lupus erythematosus patients: a cross-sectional study

Sub-Regions

• Cancer Immunotherapy and Biomarkers — 43 papers
• Multiple Sclerosis Research Studies — 25 papers
• Inflammatory Myopathies and Dermatomyositis — 22 papers
• Systemic Sclerosis and Related Diseases — 18 papers
• Genetic factors in colorectal cancer — 10 papers
• Systemic Lupus Erythematosus Research — 8 papers